SPLICEBIO
Summary
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 100 M
Avg. Deal Size£ 100 M
All rights reserved. Copyright © 2025 Datasite
Summary
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy